Citations 2
P504: UPDATED DATA FOR ZIFTOMENIB IN PATIENTS WITH NPM1-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
Fathi, Amir T. , Altman, Jessica K. , Pettit, Kirsten, Patnaik, Mrinal M. , Kremyanskaya, Marina , Baer, Maria R. , Foran, James M. , Schiller, Gary J. , Garcia, Olga Salamero, Nie, Kun , Mackey, J., Tabachri, Marilyn, Corum, Daniel, Leoni, Mollie , Dale, Stephen , Wang, Eunice S. , Issa, Ghayas , Montesinos, Pau , Botton, Stéphane de , Walter, Roland B. , Adès, Lionel , Heiblig, Maël , Peterlin, Pierre , Papayannidis, Cristina , Erba, Harry Paul
HemaSphere | August 9, 2023 | Volume: 7 | Issue: S3 | Pages: e19161da
Update on a Phase 1/2 First-in-Human Study of the Menin-KMT2A (MLL) Inhibitor Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Fathi, Amir T. , Issa, Ghayas C., Altman, Jessica K. , Montesinos, Pau , Patnaik, Mrinal M. , Foran, James M. , Baer, Maria R. , Schiller, Gary J. , Walter, Roland B. , Kremyanskaya, Marina , Pettit, Kristen , Tomkinson, Blake, Tabachri, Marilyn, Leoni, Mollie , Dale, Stephen , Montesinos, Pau , Walter, Roland B , Pettit, Kristen , Erba, Harry Paul , Issa, Ghayas , Botton, Stéphane de , Strickland, Stephen Anthony , Wang, Eunice S.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 153-156